Temple, a longevity startup, is acquiring Longevous, a London-based longevity medicine practice, as it prepares for launch, founder Deepinder Goyal said in a social media post.

Longevous founders Dr. Robert Mohr and Dr. Avi Roy are joining Temple full time.

Mohr will become chief medical officer, while Roy will become head of science.

Mohr brings nearly two decades of clinical experience, while Roy is an Oxford-trained in longevity, science, and business.

Goyal said Longevous will continue operating as part of Temple.

He added that Mohr and Roy will keep serving Longevous’ clients while working with Temple’s in-house science team.

🔗 Source: Deepinder Goyal